Robert Clark
Directeur/Bestuurslid bij INCANNEX HEALTHCARE INC.
Vermogen: 283 000 $ op 31-05-2024
Actieve functies van Robert Clark
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| INCANNEX HEALTHCARE INC. | Directeur/Bestuurslid | 17-08-2022 | - |
| Independent Dir/Board Member | 17-08-2022 | - | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Algemeen Adviseur | 01-01-2012 | - |
Loopbaan van Robert Clark
Eerdere bekende functies van Robert Clark
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 01-01-1992 | 01-01-2021 |
Opleiding van Robert Clark
| New York Medical College | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Graduate Degree | 1 |
| Corporate Officer/Principal | 1 |
| Director/Board Member | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| INCANNEX HEALTHCARE INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
- Beurs
- Insiders
- Robert Clark
- Ervaring
